INIS Stock Overview
International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally.
International Isotopes Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.041|
|52 Week High||US$0.10|
|52 Week Low||US$0.03|
|1 Month Change||2.24%|
|3 Month Change||-38.81%|
|1 Year Change||-38.81%|
|3 Year Change||-31.09%|
|5 Year Change||-52.28%|
|Change since IPO||-99.56%|
Recent News & Updates
|INIS||US Life Sciences||US Market|
Return vs Industry: INIS underperformed the US Life Sciences industry which returned -25.2% over the past year.
Return vs Market: INIS underperformed the US Market which returned -14.9% over the past year.
|INIS Average Weekly Movement||27.7%|
|Life Sciences Industry Average Movement||11.4%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.7%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: INIS is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 28% a week.
Volatility Over Time: INIS's weekly volatility has increased from 19% to 28% over the past year.
About the Company
International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through five segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry.
International Isotopes Inc. Fundamentals Summary
|INIS fundamental statistics|
Is INIS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|INIS income statement (TTM)|
|Cost of Revenue||US$4.39m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.00083|
|Net Profit Margin||4.18%|
How did INIS perform over the long term?See historical performance and comparison